09/09/2015 // JusticeNewsFlash // (press release)
New Jersey – Product liability lawsuits filed over alleged defects linked to the blood-thinning medication Xarelto are on the rise, a funding firm says. As reported on Yahoo! Finance, New Jersey based lawsuit funding firm Fair Rate Funding, says the number of claims filed in the Philadelphia Court of Common Pleas has arisen to more than 300 cases in recent months.
The number of lawsuits are also stated to be on the rise in the multidistrict litigation in Louisiana totaling more than 400 cases in US District Court. Some sources report that the total number of Xarelto lawsuits are over 1,200 nationwide.
The claims have been filed against Janssen Pharmaceutical Division, a subsidiary of Bayer and Johnson & Johnson. The lawsuits allege that use of the blood thinner has been linked to serious health problems that in some cases can prove fatal.
Fair Rate Funding provides legal financial support for plaintiffs who have retained an attorney and are involved in personal injury lawsuits for Xarelto cases and other types of claims.
More stories related to Johnson & Johnson
Source: Yahoo! Finance News Story Link: http://finance.yahoo.com/news/xarelto-lawsuit-funding-firm-fair-175200085.html;_ylt=AwrC1CgYaupVqwoAKhvQtDMD;_ylu=X3oDMTBybGY3bmpvBGNvbG8DYmYxBHBvcwMyBHZ0aWQDBHNlYwNzcg–